Advanced search
Publication Cover
Modern Rheumatology Volume 19, 2009 - Issue 2
Journal homepage
110
Views
38
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE

Clinical and histopathological features of myopathies in Japanese patients with anti-SRP autoantibodies

Tetsuya TakadaDivision of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo 160-8582, Japan
,
Michito HirakataDivision of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo 160-8582, JapanCorrespondence[email protected]
,
Akira SuwaDivision of Rheumatology, Department of Internal Medicine, Tokai University School of Medicine, Isehara, Kanagawa 259-1193, Japan
,
Yuko KanekoDivision of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo 160-8582, Japan
,
Masataka KuwanaDivision of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo 160-8582, Japan
,
Tadayuki IshiharaHakone National Hospital, Kazamatsuri 412, Odawara, Kanagawa 250-0032, Japan
&
Yasuo IkedaDivision of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo 160-8582, Japan
 show all
Pages 156-164 | Received 13 Sep 2008, Accepted 15 Oct 2008, Published online: 02 Jan 2014

References

  • Dalakas MC, Hohlfeld R. Polymyositis and dermatomyositis. Lancet. 2003;362:971–82.
  • Mimori T, Imura Y, Nakashima R, Yoshifuji H. Autoantibodies in idiopathic inflammatory myopathy: an update on clinical and pathophysiological significance. Curr Opin Rheumatol. 2007; 19:523–9.
  • Mimori T. Stractures targeted by the immune system in myositis. Curr Opin Rheumatol. 1996;8:521–7.
  • Targoff IN. Update on myositis-specific and myositis-associated autoantibodies. Curr Opin Rheumatol. 2000;12:475–81.
  • Hengstman GJ, van Engelen BG, van Venrooij WJ. Myositis specific autoantibodies: changing insights in pathophysiology and clinical associations. Curr Opin Rheumatol. 2004;16:692–9.
  • Love LA, Leff RL, Freser DD, Targoff IN, Darakas MC, Plotz PH, et al. A new approach to the classification of idiopathic inflammatory myopathy: myositis-specific autoantibodies define useful homogeneous patients groups. Medicine (Baltimore). 1991;70:360–74.
  • Hirakata M. Humoral aspects of polymyositis/dermatomyositis. Mod Rheumatol. 2000;10:199–206.
  • Targoff IN. Laboratory testing in the diagnosis and management of idiopathic inflammatory myopathies. Rheum Dis Clin North Am. 2002;28:859–90.
  • Hirakata M, Suwa A, Takada T, Sato S, Nagai S, Genth E, et al. Clinical and immunogenetic features of patients with autoanti-bodies to asparaginyl-transfer RNA synthetase. Arthritis Rheum. 2007;56:1295–303.
  • Hirakata M, Mimori T, Akizuki A, Craft J, Hardin JA, Homma M. Autoantibodies to small nuclear and cytoplasmic ribonu-cleoproteins in Japanese patients with inflammatory muscle disease. Arthritis Rheum. 1992;35:449–56.
  • Marguerie C, Bunn CC, Beynon HL, Bernstein RM, Hughes JM, So AK, et al. Polymyositis, pulmonary fibrosis and autoantibodies to aminoacyl-tRNA synthetase enzymes. Q J Med. 1990;77:1019–38.
  • Walter P, Lingappa VR. Mechanism of protein translocation across the endoplasmic reticulum membrane. Annu Rev Cell Biol. 1986;2:499–516.
  • Reeves WH, Nigam SK, Blobel G. Human autoantibodies reac-tive with the signal-recognition particle. Proc Natl Acad Sci USA. 1986;83:9507–11.
  • Okada N, Mimori T, Mukai R, Kashiwagi H, Hardin JA. Char-acterization of human autoantibodies that selectively precipitate the 75L RNA component of the signal recognition particle. J Immunol. 1987;138: 3219–23.
  • Targoff IN, Johnson AE, Miller FW. Autoantibodies to signal recognition particle in polymyositis. Arthritis Rheum. 1990;33: 1361–70.
  • Bohan A, Peter JB. Polymyositis and dermatomyositis (first of two parts). N Engl J Med. 1975;292:344–7.
  • Bohan A, Peter JB. Polymyositis and dermatomyositis (second of two parts). N Engl J Med. 1975;292:403–7.
  • Hirakata M, Suwa A, Nagai S, Kron MA, Trieu EP, Mimori T, et al. Anti-KS: identification of autoantibodies to asparaginyl-transfer RNA synthetase associated with interstitial lung disease. J Immunol. 1999;162:2315–20.
  • Dubowitz V, Sewry CA, Lane R. Definition of pathological changes seen in muscle biopsies. In: Dubowitz V, Sewry CA, Lane R, editors. Muscle biopsy a practical approach. 3rd ed. Philadelphia: (W.B.) Saunders; 2007. p. 91–2.
  • Dubowitz V, Sewry CA, Lane R. Histological and histochemical stains and reactions. In: Dubowitz V, Sewry CA, Lane R, editors. Muscle biopsy a practical approach. 3rd ed. Philadelphia: (W.B.) Saunders; 2007. p. 21–39.
  • Miller T, Al-Lozi MT, Lopate G, Pestronk A. Myopathy with antibodies to the signal recognition particle: clinical and pathologic features. J Neurol Neurosurg Psychiatry. 2002;73: 420–8.
  • Leff RL, Burgess SH, Miller FW, Love LA, Targoff IN, Dalalas MC, et al. Distinct seasonal patterns in the onset of adult idio-pathic inflammatory myopathy in patients with anti-Jo-1 and anti-signal recognition particle autoantibodies. Arthritis Rheum. 1991;34:1391–6.
  • Kao AH, Lacomis D, Lucas M, Fertig N, Oddis CV. Anti-signal recognition particle autoantibody in patients with and patients without idiopathic inflammatory myopathy. Arthritis Rheum. 2004;50:209–15.
  • Mozaffar T, Pestronk A. Myopathy with anti-Jo-1 antibodies: pathology in perimysium and neighbouring muscle fibers. J Neurol Neurosurg Psychiatry. 2000;68:472–8.
  • Hengstman GJ, ter Laak HJ, Vree Egberts WTM, Lundberg IE, Moutsopoulos HM, Vencovsky J, et al. Anti-signal recognition particle autoantibodies: marker of a necrotizing myopathy. Ann Rheum Dis. 2006;65:1635–8.
  • Cavanagh NP, Lake BD, McMeniman P. Congenital fiber type disproportion myopathy. A histological diagnosis with an uncertain clinical outlook. Arch Dis Child. 1979;54:735–43.
  • Innaccone ST, Brove KE, Vogler CA, Buchino JJ. Type 1 fiber size disproportion: morphometric data from 37 children with myopathic, neuropathic, or idiopathic hypotonia. Pediatr Pathol. 1987;7:395–419.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.